No source study found
Story checked
Concept Life Sciences appoints Dr Adrijana Vinter as Chief Executive Officer (opens in a new tab)
news-medical.net · 2026-10-13
Short answer
No source study foundNo clear answer.
We couldn't match the article's details against the peer-reviewed literature closely enough. The study may be paywalled, very new, or not indexed.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Concept Life Sciences appoints Dr Adrijana Vinter as Chief Executive Officer
news-medical.net · 2026-10-13
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
We couldn't find the study behind this story.
We couldn't match the article's details against the peer-reviewed literature closely enough. The study may be paywalled, very new, or not indexed.
Open claim evidenceSearch result
No source study found.
We couldn't match the article's details against the peer-reviewed literature closely enough. The study may be paywalled, very new, or not indexed.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 6Not checkedConcept Life Sciences has appointed Dr Adrijana Vinter as Chief Executive Officer.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 6Not checkedDr Vinter brings more than 20 years of experience spanning medicinal chemistry research, commercial development and executive leadership in the pharmaceutical and contract research industry sectors.View evidenceHide evidence
As statedmore than 20 years
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 6Not checkedHer most recent role was Global Head of Drug Discovery and a member of the Management Board at Selvita, where she oversaw a drug discovery business generating approximately €50 million in revenue and employing more than 400 people across Europe and the US.View evidenceHide evidence
As statedapproximately €50 million in revenue; more than 400 people
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 6Not checkedAt Selvita, her remit included developing integrated discovery services spanning chemistry, biology, DMPK, bioinformatics and translational research, including the introduction of advanced discovery platforms such as AI-supported discovery, spatial omics and translational models.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 6Not checkedPreviously, she held CEO and Chief Commercial Officer roles at Fidelta, became CEO in 2016, and helped grow its international client base and revenue before its acquisition by Selvita in 2021.View evidenceHide evidence
As stated2016; 2021
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 6Not checkedThe article says she previously held medicinal chemistry roles at PLIVA, GlaxoSmithKline and Galapagos, and that she holds a PhD in Organic Chemistry and an MBA.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.